Nanotechnology for Targeted Therapy of Atherosclerosis

Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of death in the world. Nanomedicine is a powerful tool that can be engineered to target atherosclerotic plaques for therapeutic and diagnosis purposes. In this review, advances in designing nanoparticles with t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Seyedmehdi Hossaini Nasr, Xuefei Huang
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	atherosclerosis nanomedicine drug delivery inflammation statins Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/babf0c5eedae46768126fe36c5afcab7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:babf0c5eedae46768126fe36c5afcab7
record_format	dspace
spelling	oai:doaj.org-article:babf0c5eedae46768126fe36c5afcab72021-11-12T05:41:26ZNanotechnology for Targeted Therapy of Atherosclerosis1663-981210.3389/fphar.2021.755569https://doaj.org/article/babf0c5eedae46768126fe36c5afcab72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.755569/fullhttps://doaj.org/toc/1663-9812Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of death in the world. Nanomedicine is a powerful tool that can be engineered to target atherosclerotic plaques for therapeutic and diagnosis purposes. In this review, advances in designing nanoparticles with therapeutic effects on atherosclerotic plaques known as atheroprotective nanomedicine have been summarized to stimulate further development and future translation.Seyedmehdi Hossaini NasrSeyedmehdi Hossaini NasrXuefei HuangXuefei HuangXuefei HuangFrontiers Media S.A.articleatherosclerosisnanomedicinedrug deliveryinflammationstatinsTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	atherosclerosis nanomedicine drug delivery inflammation statins Therapeutics. Pharmacology RM1-950
spellingShingle	atherosclerosis nanomedicine drug delivery inflammation statins Therapeutics. Pharmacology RM1-950 Seyedmehdi Hossaini Nasr Seyedmehdi Hossaini Nasr Xuefei Huang Xuefei Huang Xuefei Huang Nanotechnology for Targeted Therapy of Atherosclerosis
description	Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of death in the world. Nanomedicine is a powerful tool that can be engineered to target atherosclerotic plaques for therapeutic and diagnosis purposes. In this review, advances in designing nanoparticles with therapeutic effects on atherosclerotic plaques known as atheroprotective nanomedicine have been summarized to stimulate further development and future translation.
format	article
author	Seyedmehdi Hossaini Nasr Seyedmehdi Hossaini Nasr Xuefei Huang Xuefei Huang Xuefei Huang
author_facet	Seyedmehdi Hossaini Nasr Seyedmehdi Hossaini Nasr Xuefei Huang Xuefei Huang Xuefei Huang
author_sort	Seyedmehdi Hossaini Nasr
title	Nanotechnology for Targeted Therapy of Atherosclerosis
title_short	Nanotechnology for Targeted Therapy of Atherosclerosis
title_full	Nanotechnology for Targeted Therapy of Atherosclerosis
title_fullStr	Nanotechnology for Targeted Therapy of Atherosclerosis
title_full_unstemmed	Nanotechnology for Targeted Therapy of Atherosclerosis
title_sort	nanotechnology for targeted therapy of atherosclerosis
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/babf0c5eedae46768126fe36c5afcab7
work_keys_str_mv	AT seyedmehdihossaininasr nanotechnologyfortargetedtherapyofatherosclerosis AT seyedmehdihossaininasr nanotechnologyfortargetedtherapyofatherosclerosis AT xuefeihuang nanotechnologyfortargetedtherapyofatherosclerosis AT xuefeihuang nanotechnologyfortargetedtherapyofatherosclerosis AT xuefeihuang nanotechnologyfortargetedtherapyofatherosclerosis
_version_	1718431193859358720

Nanotechnology for Targeted Therapy of Atherosclerosis

Ejemplares similares